IP Library Patent Application 11818804
Patent Application
App. No. 11/818,804

Glucan preparations

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/818,804
Abstract

A method for producing particulate β-glucan utilizes surfactant extraction to reduce lipid impurities that decompose to volatile organic compounds (VOCs). The resulting particulate β-glucan is essentially free of VOCs.

Claims (13)

1 . A process for producing particulate β-glucan having immunostimulating properties, the process comprising:

treating a suspension of yeast cell walls with an alkaline solution;

treating the suspension of yeast cell walls with a surfactant; and

substantially purifying the particulate b-glucan.

2 . The process of claim 1 wherein the alkaline solution and surfactant are combined.

3 . The process of claim 1 and further comprising:

treating the suspension of yeast cells with the alkaline Solution multiple times.

4 . The process of claim 1 and further comprising:

treating the suspension of yeast cells with the surfactant multiple times.

5 . The process of claim 1 wherein the alkaline solution is sodium hydroxide.

6 . The process of claim 1 wherein the surfactant is one of octylthioglucoside, Lubrol PX, Triton X-100, sodium lauryl sulfate, sodium dodecyl sulfate, Nonidet P-40, Tween 20, ionic (anionic, cationic, amphoteric) surfactants such as alkyl sulfonlates and benzalkonium chlorides, nonionic surfactants such as polyoxyethylene hydrogenated castor oils, polyoxyethylene sorbitol fatty acid esters, polyoxyethylene sorbitan fatty acid esters, polyoxyethylene glycerol fatty acid esters, polyethylene glycol fatty acid esters and polyoxyethylene alkyl phenyl ethers or any combination thereof.

7 . A composition comprising particulate b-glucan having substantially no volatile organic compounds.

8 . A composition comprising particulate b-glucan having substantially no lipids.

Assignments (2)
SECURITY AGREEMENT Recorded Oct 6, 2008
From: BIOPOLYMER ENGINEERING, INC. (D/B/A BIOTHERA)
To: QUEENWOOD CAPITAL PARTNERS LLC
Reel/Frame 021630/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2008
From: COX, DONALD J.; YANG, REN-DER
To: BIOPOLYMER ENGINEERING, INC. DBA BIOTHERA
Reel/Frame 020441/0280 →